Paxman AB (publ)
OTC:PXMBF
Relative Value
The Relative Value of one PXMBF stock under the Base Case scenario is hidden USD. Compared to the current market price of 3.5 USD, Paxman AB (publ) is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
PXMBF Competitors Multiples
Paxman AB (publ) Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| SE |
P
|
Paxman AB (publ)
OTC:PXMBF
|
1.1B USD | 4.1 | 245.4 | 30.2 | 71.1 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
201.9B USD | 4.6 | 31 | 17.7 | 24.4 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
178.4B USD | 17.7 | 62.5 | 47.5 | 58.3 | |
| US |
|
Stryker Corp
NYSE:SYK
|
148B USD | 5.9 | 45.6 | 23 | 27.9 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
125B USD | 3.5 | 27.1 | 14.7 | 21.5 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
113.6B USD | 5.7 | 39.2 | 22.9 | 30.7 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
47.8B EUR | 2 | 22.5 | 12.4 | 17.4 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
52.6B USD | 12.2 | 49.6 | 35.2 | 39 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
50.3B USD | 2.3 | 28.6 | 11 | 18.5 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
50.3B USD | 8.3 | 46.8 | 25.8 | 28.3 | |
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
38.3B USD | 1.9 | 18.4 | 13 | 15.7 |